Status:
COMPLETED
COVID-19 Treatment Cascade Optimization Study
Lead Sponsor:
University of Illinois at Urbana-Champaign
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Comprehensive Behavioral Health Center
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable popul...
Detailed Description
This study will use the Multiphase Optimization Strategy (MOST) to optimize an adaptive intervention that successfully navigates COVID-19 medically or socially vulnerable people through a continuum of...
Eligibility Criteria
Inclusion
- over 18 years of age
- having high risk to contract COVID or develop related complications
- able to speak English
- able and willing to provide informed consent.
Exclusion
- under 18 years of age
- not at high risk to contract COVID or develop related complications
- unable to speak English
- unable and unwilling to provide informed consent
Key Trial Info
Start Date :
April 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2023
Estimated Enrollment :
554 Patients enrolled
Trial Details
Trial ID
NCT05305443
Start Date
April 4 2022
End Date
August 28 2023
Last Update
November 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comprehensive Behavioral Health Center
East Saint Louis, Illinois, United States, 62201